Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Normal dopamine transporter binding in dopa responsive dystonia.

Chin-Chang Huang1, Tzu-Chen Yen, Yi-Hsin Weng

  • 1Department of Neurology, Chang Gung Memorial Hospital, 199, Tung Hwa North Road, Taipei, Taiwan. cch0537@adm.cgmh.org.tw

Journal of Neurology
|August 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A clinically feasible framework to estimate tau pathology and clinical-biological discordance in the Alzheimer's disease spectrum.

Alzheimer's research & therapy·2026
Same author

Taiwan Clinical Practice Guidelines for Myasthenia Gravis.

Acta neurologica Taiwanica·2026
Same author

ADAS-Cog11 performance as a surrogate of tau PET burden in an Asian Alzheimer's disease cohort.

Journal of Alzheimer's disease : JAD·2026
Same author

Plasma pTau217 and Neurofilament Light Chain as Differentiative Markers for Progressive Supranuclear Palsy From Parkinson Disease.

Neurology·2025
Same author

Neuronal-specific antibody in patients with multiple system atrophy and progressive supranuclear palsy.

Journal of the Formosan Medical Association = Taiwan yi zhi·2025
Same author

Visual interpretation of [<sup>18</sup>F]Florzolotau Tau-PET imaging for differentiating alzheimer's disease and progressive supranuclear palsy.

European journal of nuclear medicine and molecular imaging·2025

Dopa-responsive dystonia (DRD) patients show normal dopamine transporter (DAT) uptake, distinguishing them from young-onset Parkinson disease (YOPD). This finding highlights DAT imaging as a key diagnostic tool for differentiating these conditions.

Area of Science:

  • Neurology
  • Nuclear Medicine
  • Neuroimaging

Background:

  • Dopa-responsive dystonia (DRD) and young-onset Parkinson disease (YOPD) can present with overlapping clinical symptoms, posing diagnostic challenges.
  • Accurate differentiation is crucial for appropriate treatment and patient management.
  • Brain magnetic resonance imaging (MRI) is often normal in DRD, necessitating advanced diagnostic techniques.

Observation:

  • This study investigated dopamine transporter (DAT) imaging using (99m)Tc-TRODAT-1 in two DRD patients from the same family.
  • DAT imaging was also performed on eight YOPD patients and sixteen healthy controls.
  • Clinical manifestations of DRD were documented in the affected family members.

Findings:

  • DRD patients exhibited normal striatal DAT uptake ratios (2.40 right, 2.30 left), comparable to normal controls (2.15 right, 2.14 left).

Related Experiment Videos

  • In contrast, YOPD patients showed significantly reduced DAT uptake ratios (1.38 right, 1.41 left).
  • A normal DAT uptake in DRD suggests intact presynaptic nigrostriatal dopaminergic terminals.

    • Implications:

    • Normal DAT imaging effectively differentiates DRD from YOPD in parkinsonian patients.
    • (99m)Tc-TRODAT-1 SPECT imaging is a reliable and convenient tool for assessing presynaptic dopaminergic terminal function.
    • This diagnostic approach aids in distinguishing between different causes of parkinsonism, improving diagnostic accuracy.